The Nakamizu Medical Group is an expert medical research group specializing in reproductive health, fertility issues, genetics, urology, obstetrics and gynecology, as well as in LGBTQIA+ medical research. Founded as a joint commissary program by the Russian Collective Initiative of Northern New Jersey and Hamamatsu Medical University of Hamamatsu, Japan, we scout and hire reproductive and genetic
medical professionals and research analysts from all around the world to help partake in our research, and fully utilizes clinical trials for treatment solutions and testing done on volunteers in order to solve world health issues pertaining to reproduction, fertility, and genetic-borne issues. As of 2020, our research has been focusing on the transmission of the COVID-19 Coronavirus (SARS-CoV-2) via sexual in*******se, as well as researching, testing, and analyzing the fertility in men from different areas of Mainland Asia struggling with raising national birth rates and population control, such as India, Pakistan, Nepal, Bangladesh, Myanmar, China (Including Taiwan and Tibet), and Japan. Currently ongoing is a s***matozoic research program conducted fully online by research analyst Tenzin Dawa Khumi, in order to detect virility in men's s***m and pe**le functionality in men of South Asian, East Asian, Southeast Asian, Northeast Asian, and Indigenous American ancestry, in order to rationalize why birth rates have been dropping in recent years outside of social factors, due to medical issues pertaining to fertility and reproductive function and health.
